miR-9 is able to suppress E-cadherin expression in breast cancer [29], resulting in the nuclear translocation of β-catenin and its binding with transcription factors T-cell factor/lymphoid enhancer factor 1, and subsequent up-regulated transcription of genes that facilitate cell proliferation and angiogenesis [29]. This evidence concerns the gene CDH1 and breast carcinoma.